Background and Study Aims: Unsedated endoscopy with ultrathin endoscopes has been shown to be an alternative to conventional endoscopy. This technique would appear to be an ideal way to screen for varices, but there is scant data for unsedated endoscopy in patients with cirrhosis. The aims of this pilot study were to evaluate whether unsedated endoscopy can be used to screen for varices and to determine how well it is tolerated in patients with hepatic dysfunction.
Patients and Methods: We prospectively evaluated unsedated esophagoscopy in 15 patients with cirrhosis who were candidates for beta-adrenergic-antagonist therapy. Patients with cirrhosis without gastrointestinal bleeding or contraindications to beta-adrenergic-antagonist therapy gave consent to the procedure. The presence and size of varices and the procedure time were recorded. After the procedure, patient tolerance, as gauged by questionnaire and willingness to repeat, was assessed.
Results: All patients tolerated the procedure without significant discomfort. The mean time of the procedure was 2 minutes. Esophageal varices were found in nine of 15 patients. Of these, one patient with Child-Pugh class C cirrhosis had large varices and was started on propranolol.
Conclusions: Unsedated esophagoscopy in patients with cirrhosis appears to be well tolerated. Given both potential safety and cost benefits over conventional endoscopy, this could be a useful method for screening for varices. A randomized trial comparing this method with standard endoscopy is warranted.
References
-
1
Pagliaro L, D'Amico G, Sorensen T I, et al.
Prevention of first bleeding in cirrhosis.
Ann Intern Med.
1992;
117
59-70
-
2
D'Amico G, Pagliaro L, Bosch J.
The treatment of portal hypertension: a meta-analytic review.
Hepatology.
1995;
22
332-335
-
3
Zaman A, Hahn M, Hapke R, et al.
A randomized trial of peroral versus transnasal unsedated endoscopy using an ultrathin videoendoscope.
Gastrointest Endosc.
1999;
49
279-284
-
4
Dean R, Dua K, Masset B, et al.
A comparative study of unsedated transnasal esophagogastroduodenoscopy and conventional EGD.
Gastrointest Endosc.
1996;
44
422-424
-
5
Franchis R, Pascal J P, Ancona E, et al.
Definitions, methodology and therapeutic strategies in portal hypertension.
J Hepatol.
1992;
15
256-261
-
6
Cales P, Zabatto B, Meskens C, et al.
Gastroesophageal endoscopic features in cirrhosis.
Gastroenterology.
1990;
98
156-162
-
7
Grace N D.
Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension.
Am J Gastroenterol.
1997;
92
1081-1091
-
8
North Italian Endoscopic Club for the Study and Treatment of Esophageal V arices.
Prediction of the first hemorrhage in patients with cirrhosis of the liver and esophageal varices.
N Engl J Med.
1988;
319
983-9
-
9
Quine M A, Bell G D, Charlton J E, et al.
Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing and endoscopy methods.
Gut.
1995;
36
462-467
-
10
Assy N, Rosser B, Grahame G, et al.
Risk of sedation for upper gastrointestinal endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis.
Gastrointest Endosc.
1999;
49
690-694
-
11
Lo G H, Lai K H, Cheng J S, et al.
Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial.
J Hepatol.
1999;
31
451-456
-
12
Kishimoto H, Sakai M, Kajiyama T, et al.
Clinical trial of prophylactic endoscopic variceal ligation for esophageal varices.
J Gastroenterol.
1997;
32
6-11
-
13
Sarin S K, Gurwant S L, Kumar M, et al.
Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.
N Engl J Med.
1999;
340
988-993
P. DarwinM. D.
Division of Gastroenterology University of Maryland
N3W62
22 S. Greene St Baltimore
MD 21 201 United States
Fax: Fax:+ 1- 410- 328- 8315
